NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 315 filers reported holding NATERA INC in Q2 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,227 | +2003683.3% | 2,717 | -47.9% | 0.00% | 0.0% |
| Q2 2023 | $6 | -100.0% | 5,213 | -51.5% | 0.00% | -80.0% |
| Q4 2021 | $675,000 | -44.2% | 10,738 | +2.0% | 0.01% | -28.6% |
| Q3 2021 | $1,210,000 | -11.9% | 10,525 | -20.8% | 0.01% | -12.5% |
| Q2 2021 | $1,373,000 | -23.0% | 13,288 | -16.7% | 0.01% | -27.3% |
| Q1 2021 | $1,784,000 | -6.3% | 15,958 | +0.4% | 0.01% | -8.3% |
| Q4 2020 | $1,904,000 | +62.6% | 15,901 | -3.3% | 0.01% | +33.3% |
| Q3 2020 | $1,171,000 | +42.1% | 16,450 | -1.2% | 0.01% | +50.0% |
| Q2 2020 | $824,000 | – | 16,650 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |